SCM
ITCI
Sarissa Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-360,000
| Closed | -$5.85M | – | 9 |
|
|
2017
Q1 | $5.85M | Hold |
360,000
| – | – | 2.31% | 6 |
|
|
2016
Q4 | $5.43M | Sell |
360,000
-315,000
| -47% | -$4.75M | 1.5% | 6 |
|
|
2016
Q3 | $10.3M | Hold |
675,000
| – | – | 2.37% | 7 |
|
|
2016
Q2 | $26.2M | Hold |
675,000
| – | – | 7.44% | 4 |
|
|
2016
Q1 | $18.8M | Hold |
675,000
| – | – | 4.13% | 7 |
|
|
2015
Q4 | $36.3M | Buy |
675,000
+35,000
| +5% | +$1.88M | 7.06% | 7 |
|
|
2015
Q3 | $25.6M | Buy |
640,000
+280,000
| +78% | +$11.2M | 6.33% | 6 |
|
|
2015
Q2 | $11.5M | Hold |
360,000
| – | – | 2.65% | 8 |
|
|
2015
Q1 | $8.6M | Hold |
360,000
| – | – | 1.81% | 11 |
|
|
2014
Q4 | $6.35M | Hold |
360,000
| – | – | 2.25% | 9 |
|
|
2014
Q3 | $4.94M | Buy |
360,000
+144,798
| +67% | +$1.99M | 1.91% | 9 |
|
|
2014
Q2 | $3.63M | Buy |
215,202
+88,507
| +70% | +$1.49M | 1.23% | 13 |
|
|
2014
Q1 | $2.3M | Buy |
+126,695
| New | +$2.3M | 0.79% | 11 |
|